TAS2R13 is a G-protein coupled bitter taste receptor that plays a crucial role in chemosensory perception. It functions as a gustducin-linked receptor that activates intracellular signaling cascades involving phospholipase C-beta-2 and TRPM5 channel gating to detect bitter compounds 1. TAS2R13 demonstrates ligand-binding capacity with various bitter compounds, including plant-derived molecules like theasinensin A from tea, which binds to a half-open cavity at the receptor's N-terminus 1. The receptor is also activated by pharmaceutical compounds, notably the anti-HIV protease inhibitors lopinavir and ritonavir, which accounts for their bitter taste 2. Functionally, TAS2R13 genetic variation, particularly the SNP rs1015443 (Ser259Asn), associates with individual differences in alcohol consumption 34. This polymorphism influences ethanol sensation perception, including bitterness intensity 4. Disease-relevant research identified TAS2R13 within taste transduction pathways associated with esophageal squamous cell carcinoma susceptibility 5, and expression of TAS2R13 was down-regulated in the taste transduction pathway in patients with unipolar depression 6. While TAS2R13 variants show associations with alcohol consumption phenotypes, demographic factors appear more influential on body composition than genetic variation alone 7.